- Home
- Publications
- Publication Search
- Publication Details
Title
Current treatment of IgA nephropathy
Authors
Keywords
-
Journal
Seminars in Immunopathology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-08
DOI
10.1007/s00281-021-00888-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGLT-2 inhibition in IgA nephropathy: the new standard of care?
- (2021) Jonathan Barratt et al. KIDNEY INTERNATIONAL
- A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
- (2021) David C. Wheeler et al. KIDNEY INTERNATIONAL
- After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.
- (2020) Thomas Rauen et al. KIDNEY INTERNATIONAL
- Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
- (2020) Richard Lafayette et al. Kidney International Reports
- Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
- (2020) David Paul Lennartz et al. JOURNAL OF NEPHROLOGY
- The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy
- (2020) Yu Ah Hong et al. Journal of Clinical Medicine
- Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
- (2020) David C Wheeler et al. Lancet Diabetes & Endocrinology
- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
- (2019) Aliza Thompson et al. Clinical Journal of the American Society of Nephrology
- Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Jürgen Floege et al. KIDNEY INTERNATIONAL
- Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial
- (2019) Li-Jun Liu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Antimalarials in IgA Nephropathy: Did Our Supportive Therapy Armamentarium Just Increase?
- (2019) Jürgen Floege AMERICAN JOURNAL OF KIDNEY DISEASES
- Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
- (2019) Sean J. Barbour et al. JAMA Internal Medicine
- GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
- (2019) Lesley A. Inker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases
- (2019) Benjamin M. P. Elyan et al. BMC Nephrology
- Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy
- (2018) Ya-Zi Yang et al. AMERICAN JOURNAL OF NEPHROLOGY
- Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
- (2018) Hitoshi Suzuki Clinical and Experimental Nephrology
- Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: a meta-analysis
- (2018) Yong Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis
- (2018) Hitoshi Suzuki et al. KIDNEY INTERNATIONAL
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy
- (2017) Ruitong Gao et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
- (2017) Thomas Rauen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
- (2017) Hernán Trimarchi et al. KIDNEY INTERNATIONAL
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
- (2017) Bengt C Fellström et al. LANCET
- Inflammation in IgA nephropathy
- (2017) Thomas Rauen et al. PEDIATRIC NEPHROLOGY
- Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)
- (2017) Federica Maritati et al. Arthritis & Rheumatology
- Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis
- (2016) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
- (2016) Hitoshi Suzuki et al. DISEASE MARKERS
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy
- (2016) Grazia Serino et al. KIDNEY INTERNATIONAL
- IgA nephropathy
- (2016) Kar Neng Lai et al. Nature Reviews Disease Primers
- Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
- (2016) Min Jeong Kim et al. PLoS One
- Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
- (2015) Junichi Yasutake et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
- (2014) Hiroyuki Yanagawa et al. PLoS One
- Prediction of Outcomes in Crescentic IgA Nephropathy in a Multicenter Cohort Study
- (2013) J. Lv et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy
- (2013) F. Berthoux et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- IgA Nephropathy
- (2013) Robert J. Wyatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study
- (2013) Cheuk-Chun Szeto et al. PLoS One
- Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters
- (2012) Hiroshi Kataoka et al. Clinical and Experimental Nephrology
- Implementation of proteomic biomarkers: making it work
- (2012) Harald Mischak et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- AKI Associated with Macroscopic Glomerular Hematuria: Clinical and Pathophysiologic Consequences
- (2011) J. A. Moreno et al. Clinical Journal of the American Society of Nephrology
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cigarette Smoking and Progression of IgA Nephropathy
- (2010) Ryohei Yamamoto et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
- (2010) C. Pozzi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy
- (2010) A. Nishiyama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Macromolecular IgA1 taken from patients with familial IgA Nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro
- (2009) Ka Ying Tam et al. KIDNEY INTERNATIONAL
- Long-term study of mycophenolate mofetil treatment in IgA nephropathy
- (2009) Sydney C.W. Tang et al. KIDNEY INTERNATIONAL
- Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy
- (2009) C. Manno et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Application of proteomic analysis to renal disease in the clinic
- (2009) Bruce A. Julian et al. Proteomics Clinical Applications
- Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial
- (2008) Jicheng Lv et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Toll-Like Receptor 9 Affects Severity of IgA Nephropathy
- (2008) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
- (2008) A. G. Gharavi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search